Akari Story

<div class='circular--portrait' style='background:#4E8BFC;color: #ffffff;font-size:4em;'>AT</div>
AKTX -- USA Stock  

USD 2.28  0.11  5.07%

Akari Stock News module provides quick insight into current market opportunities from investing in Akari Therapeutics. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Akari Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please continue to Akari Therapeutics Hype Analysis, Akari Therapeutics Correlation and Akari Therapeutics Performance.

Search Today's Stock News ...

 
Refresh
Akari Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Akari daily returns and investor perception about the current pice of Akari Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Akari Therapeutics exotic insider transaction detected
Filed transaction by Akari Therapeutics Plc officer. Unconventional Insider trading

Akari Therapeutics Plc insider trading alert for general transaction of options to purchase ordinary shares by Jimenez Pablo, Chief Medical Officer, on January 18, 2020. This event was filed by Akari Therapeutics Plc with SEC on 2015-01-02. Initial filing of beneficial ownership - SEC Form 3

Cash Floor Correlation

Click cells to compare fundamentals

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Akari Therapeutics Fundamental Analysis

We analyze Akari Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akari Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akari Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Akari Therapeutics is currently under evaluation in current ratio category among related companies. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Akari Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Akari Therapeutics stock to make a market-neutral strategy. Peer analysis of Akari Therapeutics could also be used in its relative valuation, which is a method of valuing Akari Therapeutics by comparing valuation metrics with similar companies.

Peers

Akari Therapeutics Related Equities

DVAXDynavax Technologies   2.27   
0%
41.0%
DRNADicerna Pharmaceutic   0.31   
0%
5.0%
EQEquillium   0.75   
13.0%
0%
EDITEditas Medicine   1.15   
21.0%
0%
DMACDiamedica Therapeutics   1.16   
21.0%
0%
DSGNDesign Therapeutics   1.40   
25.0%
0%
DNLIDenali Therapeutics   1.85   
33.0%
0%
DYAIDyadic International   2.99   
54.0%
0%
EARSAuris Medical   3.43   
62.0%
0%
DTILPrecision Biosciences   5.47   
100.0%
0%
Please continue to Akari Therapeutics Hype Analysis, Akari Therapeutics Correlation and Akari Therapeutics Performance. Note that the Akari Therapeutics information on this page should be used as a complementary analysis to other Akari Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Akari Therapeutics Stock analysis

When running Akari Therapeutics stock analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' stock examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go